Background: We investigated the neuroprotective properties of levosimendan, a novel inodilator, in an in vitro model of traumatic brain injury.Methods: Organotypic hippocampal brain slices from mouse pups were subjected to a focal mechanical trauma. Slices were treated after the injury with three different concentrations of levosimendan (0.001, 0.01 and 0.1 μM) and compared to vehicle-treated slices. After 72 hrs, the trauma was quantified using propidium iodide to mark the injured cells.Results: A significant dose-dependent reduction of both total and secondary tissue injury was observed in cells treated with either 0.01 or 0.1 μM levosimendan compared to vehicle-treated slices.Conclusion: Levosimendan represents a promising new pharmacological tool for neuroprotection after brain injury and warrants further investigation in an in vivo model. © 2010 Roehl et al; licensee BioMed Central Ltd.
CITATION STYLE
Roehl, A. B., Hein, M., Loetscher, P. D., Rossaint, J., Weis, J., Rossaint, R., & Coburn, M. (2010). Neuroprotective properties of levosimendan in an in vitro model of traumatic brain injury. BMC Neurology, 10. https://doi.org/10.1186/1471-2377-10-97
Mendeley helps you to discover research relevant for your work.